Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Singaporean women ; day:14 ; month:8 ; year:2020 ; pages:1-12
Osteoporosis international ; (14.8.2020), 1-12
- Urheber
-
Chandran, M.
Ganesan, G.
Tan, K.B
Reginster, J.-Y
Hiligsmann, M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00198-020-05536-4
- URN
-
urn:nbn:de:101:1-2020100720450161838765
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chandran, M.
- Ganesan, G.
- Tan, K.B
- Reginster, J.-Y
- Hiligsmann, M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
Cost-Effectiveness of Targeted Reemployment Bonuses
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
Cost-Effectiveness of Targeted Reemployment Bonuses
Cost-effectiveness of osteoporosis screening and biases in cost-effectiveness analyses
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy
Cost-effectiveness thresholds or decision-making threshold: a novel perspective
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis
The probability of cost-effectiveness
Cost-effectiveness analysis for clinicians
Real-world cost-effectiveness of denosumab for the treatment of postmenopausal osteoporosis in Taiwan
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?